W

ith a special type of stem cell that can be spun from skin or blood, researchers have developed a vaccine that helped stave off cancer in mice, opening up another branch in the booming field of immunotherapy.

Cancer cells and stem cells share some of the same molecules on their surfaces. In the new research, which was described Thursday in the journal Cell Stem Cell, scientists injected mice with their own stem cells, essentially training their immune systems to launch attacks when they identified those molecules — called antigens — elsewhere, including on cancer cells.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy